As the adoption of GLP-1 receptor agonists (GLP-1 RAs) rapidly accelerates, the food and beverage industry stand at the threshold of significant transformation. These breakthrough medications are reshaping not only individual health outcomes but also consumer preferences and expectations. In response, manufacturers, product innovators, and nutrition professionals are re-examining how to support evolving dietary patterns,… Read more »
Contributor
Professor Catherine Godson
Professor of Molecular Medicine and Director of the UCD Diabetes Complications Research Centre
Go To Contributors Articles